107
Views
6
CrossRef citations to date
0
Altmetric
Original Research

The impact of pharmaceutical interventions on the rational use of proton pump inhibitors in a Chinese hospital

, , &
Pages 21-26 | Published online: 27 Dec 2017

References

  • LarsenMDSchouMKristiansenASHallasJThe influence of hospital drug formulary policies on the prescribing patterns of proton pump inhibitors in primary careEur J Clin Pharmacol201470785986524770928
  • FreedbergDEKimLSYangYXThe risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological AssociationGastroenterology2017152470671528257716
  • MacLarenRKasselLEKiserTHFishDNProton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse eventsExpert Opin Drug Saf201514226928025423448
  • BuendgensLBruensingJMatthesMAdministration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrheaJ Crit Care2014294696e11e15
  • XuHBWangHDLiCHProton pump inhibitor use and risk of spontaneous bacterial peritonitis in cirrhotic patients: a systematic review and meta-analysisGenet Mol Res20151437490750126214428
  • LodatoFPoluzziERaschiEAppropriateness of proton pump inhibitor (PPI) prescription in patients admitted to hospital: attitudes of general practitioners and hospital physicians in ItalyEur J Intern Med201630313626926561
  • InadomiJMMcIntyreLBernardLFendrickAMStep-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIsAm J Gastroenterol20039891940194414499769
  • RamserKLSpraberyLRHamannGLGeorgeCMWillAResults of an intervention in an academic internal medicine clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary changeJ Manag Care Pharm200915434435019422274
  • BundeffAWZaikenKImpact of clinical pharmacists’ recommendations on a proton pump inhibitor taper protocol in an ambulatory care practiceJ Manag Care Pharm201319432533323627578
  • Chinese National Expert Committee on Rational Drug UseGuidelines for Chinese Doctors and Pharmacists2nd edChongqingChongqing press2014741760
  • FarrellBPottieKThompsonWDeprescribing proton pump inhibitors: evidence-based clinical practice guidelineCan Fam Physician201763535436428500192
  • ZengWFinlaysonAEShankarSde BruynWGodmanBPrescribing efficiency of proton pump inhibitors in China: influence and future directionsBMC Health Serv Res2015151125609265
  • SacharHVaidyaKLaineLIntermittent vs continuous proton pump inhibitor therapy for high-risk bleeding ulcers: a systematic review and meta-analysisJAMA Intern Med2014174111755176225201154
  • LoEAWilbyKJEnsomMHUse of proton pump inhibitors in the management of gastroesophageal varices: a systematic reviewAnn Pharmacother201549220721925583938
  • HaastrupPPaulsenMSBegtrupLMHansenJMJarbølDEStrategies for discontinuation of proton pump inhibitors: a systematic reviewFam Pract201431662563025192903
  • MacLarenRReynoldsPMAllenRRHistamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unitJAMA Intern Med2014174456457424535015
  • PappasMJollySVijanSDefining appropriate use of proton-pump inhibitors among medical inpatientsJ Gen Intern Med201631436437126553337
  • BarlettaJFSclarDAUse of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic consequencesPharmacoeconomics201432151324271943